These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35223598)

  • 1. Identification of Hub Genes in Pancreatic Ductal Adenocarcinoma Using Bioinformatics Analysis.
    Wang C; Guo J; Zhao X; Jia J; Xu W; Wan P; Sun C
    Iran J Public Health; 2021 Nov; 50(11):2238-2245. PubMed ID: 35223598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis.
    Jin D; Jiao Y; Ji J; Jiang W; Ni W; Wu Y; Ni R; Lu C; Qu L; Ni H; Liu J; Xu W; Xiao M
    PeerJ; 2020; 8():e9301. PubMed ID: 32587798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer.
    Shi H; Xu H; Chai C; Qin Z; Zhou W
    J Clin Lab Anal; 2022 May; 36(5):e24381. PubMed ID: 35403252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative bioinformatics approaches for identifying potential biomarkers and pathways involved in non-obstructive azoospermia.
    Hu T; Luo S; Xi Y; Tu X; Yang X; Zhang H; Feng J; Wang C; Zhang Y
    Transl Androl Urol; 2021 Jan; 10(1):243-257. PubMed ID: 33532314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four potential microRNAs affect the progression of pancreatic ductal adenocarcinoma by targeting MET via the PI3K/AKT signaling pathway.
    Yao LC; Jiang XH; Yan SS; Wang W; Wu L; Zhai LL; Xiang F; Ji T; Ye L; Tang ZG
    Oncol Lett; 2021 Apr; 21(4):326. PubMed ID: 33692858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
    Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
    J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Hub Genes in Type 2 Diabetes Mellitus Using Bioinformatics Analysis.
    Lin Y; Li J; Wu D; Wang F; Fang Z; Shen G
    Diabetes Metab Syndr Obes; 2020; 13():1793-1801. PubMed ID: 32547141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
    Yang Z; Wu X; Li J; Zheng Q; Niu J; Li S
    Int J Gen Med; 2021; 14():10185-10194. PubMed ID: 34992437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.
    Dai H; Guo L; Lin M; Cheng Z; Li J; Tang J; Huan X; Huang Y; Xu K
    PeerJ; 2020; 8():e10265. PubMed ID: 33240619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential target genes in pancreatic ductal adenocarcinoma by bioinformatics analysis.
    Tang Y; Zhang Z; Tang Y; Chen X; Zhou J
    Oncol Lett; 2018 Aug; 16(2):2453-2461. PubMed ID: 30013637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Key Genes Involved in Diabetic Peripheral Neuropathy Progression and Associated with Pancreatic Cancer.
    Jian L; Yang G
    Diabetes Metab Syndr Obes; 2020; 13():463-476. PubMed ID: 32110079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Inflammation-related Genes as Potential Diagnostic Biomarkers of Sepsis.
    Guo P; Wang R; Shen J; Zhang L; Mo W
    Altern Ther Health Med; 2023 Jul; 29(5):24-31. PubMed ID: 37235492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key regulators of pancreatic ductal adenocarcinoma using bioinformatics analysis of microarray data.
    Li N; Zhao X; You S
    Medicine (Baltimore); 2019 Jan; 98(2):e14074. PubMed ID: 30633213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
    Zhang X; Yang L; Chen W; Kong M
    Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic Analysis Combined With Experimental Validation Reveals Novel Hub Genes and Pathways Associated With Focal Segmental Glomerulosclerosis.
    Hou YP; Diao TT; Xu ZH; Mao XY; Wang C; Li B
    Front Mol Biosci; 2021; 8():691966. PubMed ID: 35059432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.